EKSOEKSO BIONICS HOLDINGS, INC.

Nasdaq eksobionics.com


$ 1.00 $ -0.01 (-1 %)    

Thursday, 08-Aug-2024 11:22:56 EDT
QQQ $ 448.85 $ 3.08 (0.69 %)
DIA $ 395.20 $ 1.65 (0.42 %)
SPY $ 531.85 $ 3.22 (0.61 %)
TLT $ 96.23 $ 0.08 (0.08 %)
GLD $ 224.50 $ -0.33 (-0.15 %)
$ 0.995
$ 1.01 x 100
-- x --
-- - --
$ 0.62 - $ 3.13
82,330
na
18.35M
$ 1.06
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-29-2024 06-30-2024 10-Q
2 04-29-2024 03-31-2024 10-Q
3 03-04-2024 12-31-2023 10-K
4 10-26-2023 09-30-2023 10-Q
5 07-27-2023 06-30-2023 10-Q
6 04-27-2023 03-31-2023 10-Q
7 03-28-2023 12-31-2022 10-K
8 11-03-2022 09-30-2022 10-Q
9 07-28-2022 06-30-2022 10-Q
10 04-28-2022 03-31-2022 10-Q
11 02-24-2022 12-31-2021 10-K
12 11-02-2021 09-30-2021 10-Q
13 07-29-2021 06-30-2021 10-Q
14 04-29-2021 03-31-2021 10-Q
15 02-25-2021 12-31-2020 10-K
16 10-29-2020 09-30-2020 10-Q
17 07-31-2020 06-30-2020 10-Q
18 04-30-2020 03-31-2020 10-Q
19 02-27-2020 12-31-2019 10-K
20 10-30-2019 09-30-2019 10-Q
21 08-01-2019 06-30-2019 10-Q
22 05-01-2019 03-31-2019 10-Q
23 02-28-2019 12-31-2018 10-K
24 11-07-2018 09-30-2018 10-Q
25 08-07-2018 06-30-2018 10-Q
26 05-07-2018 03-31-2018 10-Q
27 03-13-2018 12-31-2017 10-K
28 11-08-2017 09-30-2017 10-Q
29 08-07-2017 06-30-2017 10-Q
30 05-09-2017 03-31-2017 10-Q
31 03-15-2017 12-31-2016 10-K
32 11-09-2016 09-30-2016 10-Q
33 08-03-2016 06-30-2016 10-Q
34 05-10-2016 03-31-2016 10-Q
35 03-14-2016 12-31-2015 10-K
36 11-09-2015 09-30-2015 10-Q
37 08-12-2015 06-30-2015 10-Q
38 05-11-2015 03-31-2015 10-Q
39 03-19-2015 12-31-2014 10-K
40 11-12-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 hc-wainwright--co-reiterates-buy-on-ekso-bionics-holdings-maintains-10-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy and maintai...

 ekso-bionics-holdings-q2-2024-gaap-eps-013-beats-014-estimate-sales-4950m-miss-5171m-estimate

Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of...

 ekso-bionics-announces-research-partnership-with-shepherd-center-to-expand-use-of-eksonr-and-ekso-indego-devices-in-rehabilitation-and-community-settings

Aims To Improve Patient Quality Of Life For Those With Spinal Cord And Brain Injuries, Multi-Trauma, Amputations, Stroke, Multi...

 lake-street-initiates-coverage-on-ekso-bionics-holdings-with-buy-rating-announces-price-target-of-25

Lake Street analyst Ben Haynor initiates coverage on Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy rating and announces Pri...

 hc-wainwright--co-maintains-buy-on-ekso-bionics-holdings-raises-price-target-to-10

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy and raises t...

 ekso-bionics-holdings-q1-2024-gaap-eps-020-misses-016-estimate-sales-3756m-miss-4993m-estimate

Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(0.20) per share which missed the analyst consensus estimate ...

 cognition-therapeutics-and-2-other-stocks-under-2-insiders-are-buying

The Dow Jones index closed lower by more than 100 points on Thursday. When insiders purchase or sell shares, it indicates their...

 why-sophia-genetics-shares-are-trading-lower-by-19-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Shares of SOPHiA GENETICS SA (NASDAQ: SOPH) fell sharply during Tuesday’s session after the company reported worse than expect...

 hc-wainwright--co-maintains-buy-on-ekso-bionics-holdings-lowers-price-target-to-925

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Ekso Bionics Holdings (NASDAQ:EKSO) with a Buy and lowers t...

 why-paymentus-shares-are-trading-higher-by-around-18-here-are-20-stocks-moving-premarket

Shares of Paymentus Holdings, Inc. (NYSE: PAY) rose sharply in today’s pre-market trading after the company reported better-th...

 ekso-bionics-holdings-q4-2023-gaap-eps-0220-misses-0110-estimate-sales-4847m-beat-4773m-estimate

Ekso Bionics Holdings (NASDAQ:EKSO) reported quarterly losses of $(0.220) per share which missed the analyst consensus estimate...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION